Search research articles
Contact Us
Filters
Showing results (721-730 of 764) with videos related to
Page
of 77
Sort By:
Cancer
|
April 8, 2011
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
Siqing Fu, Wei Hu, Revathy Iyer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 16, 2010
Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice
Jamil A Haque, Ryan S McMahan, Jean S Campbell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 26, 2006
Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity
Zalfa A Abdel-Malek, Ana Luisa Kadekaro, Renny J Kavanagh, et al.
Inhalation Toxicology
|
July 2, 2013
Glutathione (GSH) and the GSH synthesis gene Gclm modulate plasma redox and vascular responses to acute diesel exhaust inhalation in mice
Chad S Weldy, Ian P Luttrell, Collin C White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1996
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum
J J Kavanagh, A P Kudelka, C G de Leon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
A P Kudelka, D Tresukosol, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma
R S Freedman, A P Kudelka, J J Kavanagh, et al.
Environmental Research
|
April 10, 2010
A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age
Todd A Jusko, Anneclaire J De Roos, Stephen M Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma
Renato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.
Seminars in Oncology
|
February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
David S Alberts, Franco M Muggia, James Carmichael, et al.
Page
of 77
Search research articles
Search
Showing results (721-730 of 764) with videos related to
Sort By:
Page
of 77
Cancer
|
April 8, 2011
Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
Siqing Fu, Wei Hu, Revathy Iyer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 16, 2010
Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice
Jamil A Haque, Ryan S McMahan, Jean S Campbell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 26, 2006
Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity
Zalfa A Abdel-Malek, Ana Luisa Kadekaro, Renny J Kavanagh, et al.
Inhalation Toxicology
|
July 2, 2013
Glutathione (GSH) and the GSH synthesis gene Gclm modulate plasma redox and vascular responses to acute diesel exhaust inhalation in mice
Chad S Weldy, Ian P Luttrell, Collin C White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1996
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum
J J Kavanagh, A P Kudelka, C G de Leon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
A P Kudelka, D Tresukosol, C L Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma
R S Freedman, A P Kudelka, J J Kavanagh, et al.
Environmental Research
|
April 10, 2010
A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age
Todd A Jusko, Anneclaire J De Roos, Stephen M Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma
Renato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.
Seminars in Oncology
|
February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
David S Alberts, Franco M Muggia, James Carmichael, et al.
Page
of 77